Navigation Links
Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage
Date:9/16/2009

WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.

According to available information, Glaxo failed to properly test the drug and urged scientists to conceal Paxil's risks. The Philadelphia trial is the first of more than 600 cases against the London-based company.

Are you satisfied with the way your regular news sources report on these important stories? If not, try Pharmaceutical Industry Today (http://pharmaceuticals.einnews.com/), for free, to see what you may have been missing.

See:

-- GlaxoSmithKline News - http://pharmaceuticals.einnews.com/news/glaxosmithkline

-- Paxil News - http://pharmaceuticals.einnews.com/news/paxil

-- Latest Pharmaceutical News - http://pharmaceuticals.einnews.com/

For a free trial to Pharmaceutical Industry Today, go to: http://pharmaceuticals.einnews.com/users/register.php

About the publisher of Pharmaceutical Industry Today, EIN News, http://www.einnews.com/

EIN News was established in 1995, and through the years has built more than 200,000 news feeds organized within over 80 individual news sites. The company has launched the well-known 'Russia News Service' brand and opened Internet news access to China with 'Inside China Today'.

Offering a unique combination of human editing and proprietary scanning software, EIN News won Europe's coveted Momentum Award as the most innovative internet company on the continent. Serving millions of customers, the company distributes its feeds via email or mobile news alerts, online and other channels such as Newsfeed Maker (http://www.newsfeedmaker.com/) and EIN Presswire (http://www.einpresswire.com/).


'/>"/>
SOURCE EIN News
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. By 2018, GlaxoSmithKlines Votrient Will Garner Sales of $640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader
2. GlaxoSmithKline Statement Confirming alli Safety
3. Mahindra Satyam Signs 5 Year SAP Contract with GlaxoSmithKline
4. GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare
5. GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
6. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
7. GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
8. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
9. GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
10. GlaxoSmithKline Update: Influenza A (H1N1)
11. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality ... Management Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively ... Management Alerts and Dashboards provide near real-time data about patients admitted to and/or ...
(Date:6/23/2017)... ... ... By scoring 100% for fiscal management and accountability, the Arthritis National Research ... Charity Navigator, validating ANRF's work as a top charity in America. , This achievement ... earns ANRF a spot on their “ 10 Charities Worth Watching ” list as ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or from ... how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, ... symptoms of AMD? A study published recently in Dove Medical Press journal, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. Ran Y. ... has recently begun offering three new minimally invasive procedures to patients who want ... reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, and platelet ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ® ... they will host a live, complimentary webinar titled, "Untangling ... benchtop to the real world" on Wednesday June 28, ... This webinar will feature interviews with recreational ... into the manipulation techniques abusers use to prepare opioid ...
(Date:6/14/2017)... , June 14, 2017  ivWatch LLC, a ... effectiveness of intravenous (IV) therapy, is pleased to announce ... category of Nonsurgical Hospital Supplies and Equipment at the ... program for the medtech industry. The award was presented ... Jacob K. Javits Center in New York ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, Inc. ... today announced that the U.S. Food and Drug Administration (FDA) ... 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter ... manufacturing facility is a measure of the progress we have ...
Breaking Medicine Technology: